Ropinirole 24-hour prolonged release
- 3 April 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 68 (14) , 1108-1115
- https://doi.org/10.1212/01.wnl.0000258660.74391.c1
Abstract
Objective: To evaluate the efficacy of ropinirole 24-hour prolonged release (ropinirole 24-hour) as an adjunct to levodopa in patients with Parkinson disease (PD) and motor fluctuations.Keywords
This publication has 9 references indexed in Scilit:
- Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trialThe Lancet, 2005
- A Randomized Placebo-Controlled Trial of Rasagiline in Levodopa-Treated Patients With Parkinson Disease and Motor FluctuationsArchives of Neurology, 2005
- A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa.Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2002
- A 3-year randomized trial of ropinirole and bromocriptine in early Parkinson’s diseaseNeurology, 1999
- Entacapone enhances the response to levodopa in parkinsonian patients with motor fluctuationsNeurology, 1998
- A multicenter trial of ropinirole as adjunct treatment for Parkinson's diseaseNeurology, 1998
- Entacapone improves motor fluctuations in levodopa‐ treated Parkinson's disease patientsAnnals of Neurology, 1997
- Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's diseaseNeurology, 1997
- Ropinirole for the treatment of early Parkinson's diseaseNeurology, 1997